keyword
https://read.qxmd.com/read/34460985/telemedicine-in-epilepsy-management-during-the-coronavirus-disease-2019-pandemic
#21
JOURNAL ARTICLE
Kenjiro Kikuchi, Shin-Ichiro Hamano, Ayumi Horiguchi, Hazuki Nonoyama, Yuko Hirata, Ryuki Matsuura, Reiko Koichihara, Akira Oka, Daishi Hirano
BACKGROUND: Telemedicine has spread rapidly during the coronavirus disease 2019 (COVID-19) pandemic and shown its usefulness, particularly for patients with epilepsy, compared to face-to-face visits. We sought to evaluate the clinical features of patients with childhood onset epilepsy associated with consultations by telephone call during the COVID-19 pandemic. METHODS: We retrospectively investigated the medical records of patients with childhood onset epilepsy who visited an outpatient clinic in Saitama Children's Medical Center, Saitama, Japan, from 1 March 2020 to 30 September 2020...
January 2022: Pediatrics International: Official Journal of the Japan Pediatric Society
https://read.qxmd.com/read/34254497/anaphylaxis-to-levetiracetam-in-an-adolescent-a-very-rare-occurence
#22
Şeyma Kahraman, Şeyda Değermenci, Mehmet Ali Oktay, Deniz Menderes, Okşan Derinöz Güleryüz, Ebru Arhan, Arzu Bakırtaş, Hacer İlbilge Ertoy-Karagöl
BACKGROUND: Antiepileptic drugs (AEDs) are among the most common causes of severe delayed-type hypersensitivity reactions such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and Drug Reaction with Eosinophilia and Systemic Symptoms(DRESS) in children. These reactions are more commonly seen with aromatic AEDs such as phenytoin and carbamazepine than the non-aromatic or new generation AEDs. However immediate-type hypersensitivity reactions such as urticaria/angioedema, anaphylaxis are very rare with AEDs...
2021: Turkish Journal of Pediatrics
https://read.qxmd.com/read/34190172/detrimental-effect-of-antiepileptic-drugs-dose-in-pediatric-children-with-epilepsy-in-saudi-arabia-a-prospective-cohort-study
#23
JOURNAL ARTICLE
Badriyah S Alotaibi, Abdulaziz A Alodhayani, Ashraf Alwan, Khalid Nijr Alotaibi, Brahim Tabarki Melaiki, Aljawharah Mohammad Almadhi, Lulwah Haitham Alfares, Nahlah Ahmed Alalkami
This study aims to evaluate the effect of dose titration for different oral antiepileptic medications among children with epilepsy in Riyadh, Saudi Arabia.A single-center prospective pilot, cohort study was undertaken at a tertiary hospital in Riyadh, Saudi Arabia. All medical records of pediatric patients below the age of 14 years of age who has been newly diagnosed with epilepsy by attending a medical specialist or on a new epileptic treatment plans were enrolled in the study.A total of 76 epileptic patients were screened for 3 months' period and 48 patients were included in this study...
July 2, 2021: Medicine (Baltimore)
https://read.qxmd.com/read/34053206/current-pharmacologic-strategies-for-treatment-of-intractable-epilepsy-in-children
#24
JOURNAL ARTICLE
Ja Un Moon, Kyung-Ok Cho
Epileptic encephalopathy (EE) is a devastating pediatric disease that features medically resistant seizures, which can contribute to global developmental delays. Despite technological advancements in genetics, the neurobiological mechanisms of EEs are not fully understood, leaving few therapeutic options for affected patients. In this review, we introduce the most common EEs in pediatrics (i.e., Ohtahara syndrome, Dravet syndrome, and Lennox-Gastaut syndrome) and their molecular mechanisms that cause excitation/inhibition imbalances...
May 2021: International Neurourology Journal
https://read.qxmd.com/read/34001397/risk-of-seizure-recurrence-after-a-first-unprovoked-seizure-in-childhood
#25
JOURNAL ARTICLE
Yuichi Takami, Taku Nakagawa
OBJECTIVE: The aim of this study was to assess the risk of recurrence after a first unprovoked seizure in childhood and to explore the correlation between the first and second seizures in recurrent patients. METHODS: In a prospective study, we included 467 children aged 1 month to 16 years, who were attended to between November 1, 2008 and October 31, 2016 following a first seizure. Children who had been started on treatment with antiepileptic drugs were excluded...
September 2021: Brain & Development
https://read.qxmd.com/read/33936301/acute-symptomatic-seizures-in-critically-ill-children-frequency-etiology-and-outcomes
#26
JOURNAL ARTICLE
Sanam B Rajper, Mujtaba Moazzam, Arsheen Zeeshan, Qalab Abbas
BACKGROUND: Critically ill individuals have an increased risk of acute symptomatic seizures secondary to systemic illnesses; unrecognized or untreated seizures can quickly convert into status epilepticus, which is associated with high morbidity and mortality. OBJECTIVE: The aim of this study was to determine frequency, etiology, and outcome of seizures in critical ill children admitted in intensive care unit of a tertiary care hospital. MATERIALS AND METHODS: Retrospective review of medical records of all children admitted in pediatric intensive care unit (PICU) of the Aga Khan University from January 2016 to December 2018 and who had a new-onset seizure irrespective of underlying diagnosis was carried out after ethical review committee approval...
October 2020: Journal of Pediatric Neurosciences
https://read.qxmd.com/read/33857522/the-pediatric-psychopharmacology-of-autism-spectrum-disorder-a-systematic-review-part-i-the-past-and-the-present
#27
JOURNAL ARTICLE
Antonio M Persico, Arianna Ricciardello, Marco Lamberti, Laura Turriziani, Francesca Cucinotta, Claudia Brogna, Benedetto Vitiello, Celso Arango
Autism Spectrum Disorder (ASD) is a severe and lifelong neurodevelopmental disorder, with high social costs and a dramatic burden on the quality of life of patients and family members. Despite its high prevalence, reaching 1/54 children and 1/45 adults in the United States, no pharmacological treatment is still directed to core symptoms of ASD, encompassing social and communication deficits, repetitive behaviors, restricted interests, and abnormal sensory processing. The purpose of this review is to provide an overview of the state-of-the-art of psychopharmacological therapy available today for ASD in children and adolescents, in order to foster best practices and to organize new strategies for future research...
August 30, 2021: Progress in Neuro-psychopharmacology & Biological Psychiatry
https://read.qxmd.com/read/33244764/dosing-recommendations-for-lamotrigine-in-children-evaluation-based-on-previous-and-new-population-pharmacokinetic-models
#28
JOURNAL ARTICLE
Manon Tauzin, Jean-Marc Tréluyer, Rima Nabbout, Thierry Billette de Villemeur, Isabelle Desguerre, Radia Aboura, Ines Gana, Yi Zheng, Sihem Benaboud, Naim Bouazza, Camille Chenevier-Gobeaux, Cécile Freihuber, Déborah Hirt
Lamotrigine is a broad-spectrum antiepileptic drug with high inter-individual variability in serum concentrations in children. The aims of this study were to evaluate the predictive performance of pediatric population pharmacokinetic (PPK) models published on lamotrigine, to build a new model with our monitoring data and to evaluate the current recommended doses. A validation cohort included patients treated with lamotrigine who had a serum level assayed during therapeutic drug monitoring (TDM). PPK models published in the literature were first applied to the validation cohort...
November 26, 2020: Journal of Clinical Pharmacology
https://read.qxmd.com/read/33048338/recommendations-for-the-treatment-of-epilepsy-in-adult-and-pediatric-patients-in-belgium-2020-update
#29
JOURNAL ARTICLE
Paul Boon, Susana Ferrao Santos, Anna C Jansen, Lieven Lagae, Benjamin Legros, Sarah Weckhuysen
To guide health care professionals in Belgium in selecting the appropriate antiepileptic drugs (AEDs) for their epilepsy patients, a group of Belgian epilepsy experts developed recommendations for AED treatment in adults and children (initial recommendations in 2008, updated in 2012). As new drugs have become available, others have been withdrawn, new indications have been approved and recommendations for pregnant women have changed, a new update was pertinent. A group of Belgian epilepsy experts (partly overlapping with the group in charge of the 2008/2012 recommendations) evaluated the most recent international guidelines and relevant literature for their applicability to the Belgian situation (registration status, reimbursement, clinical practice) and updated the recommendations for initial monotherapy in adults and children and add-on treatment in adults...
February 2021: Acta Neurologica Belgica
https://read.qxmd.com/read/32266577/risk-of-seizures-associated-with-antipsychotic-treatment-in-pediatrics-with-psychiatric-disorders-a-nested-case-control-study-in-korea
#30
JOURNAL ARTICLE
Soo Min Jeon, Susan Park, Dohoon Kim, Jin-Won Kwon
Antipsychotic drugs raise seizure risk in adults, and antipsychotic drug use is increasing among pediatric psychiatric disorder patients. However, few studies have examined seizure risk in this younger patient population. To evaluate seizure risk in pediatric patients on antipsychotics, we conducted a nested case-control study using a nationwide database. Patient information was retrieved from the Korean Health Insurance Review and Assessment (HIRA) database from 2008-2018. Antipsychotic use among newly diagnosed psychiatric patients was gathered starting 1 year before the index date and categorized as recent, past, consistent, or none...
April 7, 2020: European Child & Adolescent Psychiatry
https://read.qxmd.com/read/32239268/expert-opinion-use-of-valproate-in-girls-and-women-of-childbearing-potential-with-epilepsy-recommendations-and-alternatives-based-on-a-review-of-the-literature-and-clinical-experience-a-european-perspective
#31
REVIEW
Manuel Toledo, Barbara Mostacci, Magdalena Bosak, Joanna Jedrzejzak, Rhys H Thomas, Javier Salas-Puig, Arnaud Biraben, Bettina Schmitz
Valproate is a broad-spectrum antiepileptic drug (AED) of particular interest in pediatric epilepsy syndromes and idiopathic generalized epilepsy, as it is relatively more effective in these syndromes than other AEDs. In 2018, the European Medicines Agency introduced new restrictions on the use of valproate in girls and women of childbearing potential to avoid exposure during pregnancy. The strengthening of existing restrictions sparked controversy and debate among patients and the medical community. The high prevalence of epilepsy syndromes amenable to valproate treatment in women of childbearing age and the little information available on the teratogenic potential of alternative treatments have created uncertainty on how to manage these patients...
August 2021: Journal of Neurology
https://read.qxmd.com/read/31990368/rapid-versus-slow-withdrawal-of-antiepileptic-drugs
#32
JOURNAL ARTICLE
Fernando Ayuga Loro, Enrique Gisbert Tijeras, Francesco Brigo
BACKGROUND: The ideal objective of treating a person with epilepsy is to induce remission (free of seizures for some time) using antiepileptic drugs (AEDs) and withdraw the AEDs without causing seizure recurrence. Prolonged usage of AEDs may have long-term adverse effects. Hence, when a person with epilepsy is in remission, it is logical to attempt to discontinue the medication. The timing of withdrawal and the mode of withdrawal arise while contemplating withdrawal of AEDs. This review examines the evidence for the rate of withdrawal of AEDs (whether rapid or slow tapering) and its effect on seizure recurrence...
January 23, 2020: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/31964545/diagnostic-evaluation-and-management-of-seizures-and-status-epilepticus-in-children-with-known-epilepsy-or-new-onset-seizures-a-retrospective-and-comparative-analysis
#33
JOURNAL ARTICLE
J Le Coz, G Chéron, R Nabbout, G Patteau, C Heilbronner, P Hubert, S Renolleau, M Oualha
OBJECTIVES: The purpose of this study was to describe and compare the initial management, including clinical/biological investigation and treatment, of new-onset seizures and status epilepticus (SE) in children versus seizures and SE in those with known epilepsy. METHODS: This was a retrospective, single-center, observational study conducted in an urban pediatric hospital in Paris. All patients, aged from 1 month to 18 years, admitted to the pediatric intensive care unit, the high-dependency care unit, and those who required hospitalization in the short-term unit of the emergency department between January 1 and December 31, 2014 for seizures and/or SE were included...
February 2020: Archives de Pédiatrie: Organe Officiel de la Sociéte Française de Pédiatrie
https://read.qxmd.com/read/31617449/safety-and-efficacy-of-brivaracetam-in-pediatric-refractory-epilepsy-a-single-center-clinical-experience
#34
JOURNAL ARTICLE
Sara McGuire, Gustavo Silva, Darshan Lal, Divya S Khurana, Agustin Legido, Daphne Hasbani, Karen S Carvalho, Joseph Melvin, Ignacio Valencia
Brivaracetam is a new antiepileptic drug with limited data in children. The objective of this study was to assess the efficacy/tolerability of brivaracetam. This is a retrospective chart review of children/adolescents with refractory epilepsy treated with brivaracetam from 2016 to 2018. The primary outcome was seizure reduction (decrease in seizure frequency >50%). Twenty-three patients were identified. Mean age at initiation was 12.5 years. Fourteen were females. Epilepsy was focal in 11, generalized in 6, and mixed in 3...
February 2020: Journal of Child Neurology
https://read.qxmd.com/read/31374487/safety-and-tolerability-of-adjunctive-lacosamide-in-a-pediatric-population-with-focal-seizures-an-open-label-trial
#35
MULTICENTER STUDY
Jose A Ferreira, Jean-Baptiste Le Pichon, Ahmed T Abdelmoity, Deanne Dilley, Peter Dedeken, Tony Daniels, William Byrnes
PURPOSE: To evaluate safety and tolerability of adjunctive lacosamide in children with focal seizures. METHODS: Patients were eligible for this open-label, fixed-titration trial (SP0847; NCT00938431) if aged 1 month-17 years with focal seizures taking 1-3 antiepileptic drugs. Findings from Cohort 1, aged 5-11 years, who received lacosamide ≤8 mg/kg/day, informed dosing for age-based cohorts 2-5, who then received ≤12 mg/kg/day (≤600 mg/day). Oral lacosamide was initiated at 2 mg/kg/day (1 mg/kg bid) and uptitrated by 2 mg/kg/day/week to the maximum cohort-defined dose (maximum trial duration: 13 weeks)...
October 2019: Seizure: the Journal of the British Epilepsy Association
https://read.qxmd.com/read/31326720/clinical-outcomes-of-closed-loop-vagal-nerve-stimulation-in-patients-with-refractory-epilepsy
#36
JOURNAL ARTICLE
Michal Tzadok, Amit Harush, Andrea Nissenkorn, Yaacov Zauberman, Zeev Feldman, Bruria Ben-Zeev
PURPOSE: The AspireSR® is a vagal nerve stimulation (VNS) device that operates as a closed-loop system, delivering an automatic stimulation in response to an ictal heart rate increase that serves as a predictor for an imminent seizure. Our purpose is to assess the outcome of the AspireSR® in a patient population managed in a pediatric neurology unit. METHODS: The records of patients who underwent transplantation during 2015-2017 and are continuously followed in one pediatric-epilepsy clinic, were retrospectively analyzed...
October 2019: Seizure: the Journal of the British Epilepsy Association
https://read.qxmd.com/read/31238702/concentrations-of-the-selected-biomarkers-of-endothelial-dysfunction-in-response-to-antiepileptic-drugs-a-literature-review
#37
JOURNAL ARTICLE
Beata Sarecka-Hujar, Izabela Szołtysek-Bołdys, Ilona Kopyta, Barbara Dolińska, Andrzej Sobczak
Epilepsy is a disease arising from morphological and metabolic changes in the brain. Approximately 60% of patients with seizures can be controlled with 1 antiepileptic drug (AED), while in others, polytherapy is required. The AED treatment affects a number of biochemical processes in the body, including increasing the risk of cardiovascular diseases (CVDs). It is indicated that the duration of AED therapy with some AEDs significantly accelerates the process of atherosclerosis. Most of AEDs increase levels of homocysteine (HCys) as well as may affect concentrations of new, nonclassical risk factors for atherosclerosis, that is, asymmetric dimethylarginine (ADMA) and homoarginine (hArg)...
January 2019: Clinical and Applied Thrombosis/hemostasis
https://read.qxmd.com/read/31229939/smartphone-eeg-and-remote-online-interpretation-for-children-with-epilepsy-in-the-republic-of-guinea-quality-characteristics-and-practice-implications
#38
JOURNAL ARTICLE
Jennifer A Williams, Fodé Abass Cisse, Mike Schaekermann, Foksouna Sakadi, Nana Rahamatou Tassiou, Gladia C Hotan, Aissatou Kenda Bah, Abdoul Bachir Djibo Hamani, Andrew Lim, Edward C W Leung, Tadeu A Fantaneanu, Tracey A Milligan, Vidita Khatri, Daniel B Hoch, Manav V Vyas, Alice D Lam, Joseph M Cohen, Andre C Vogel, Edith Law, Farrah J Mateen
PURPOSE: Children with epilepsy in low-income countries often go undiagnosed and untreated. We examine a portable, low-cost smartphone-based EEG technology in a heterogeneous pediatric epilepsy cohort in the West African Republic of Guinea. METHODS: Children with epilepsy were recruited at the Ignace Deen Hospital in Conakry, 2017. Participants underwent sequential EEG recordings with an app-based EEG, the Smartphone Brain Scanner-2 (SBS2) and a standard Xltek EEG...
October 2019: Seizure: the Journal of the British Epilepsy Association
https://read.qxmd.com/read/30978636/parental-stress-in-pediatric-epilepsy-after-therapy-withdrawal
#39
JOURNAL ARTICLE
Francesca Felicia Operto, Roberta Mazza, Grazia Maria Giovanna Pastorino, Stella Campanozzi, Lucia Margari, Giangennaro Coppola
OBJECTIVE: The objective of the study was to explore stress levels in the parents of children with idiopathic epilepsy at different time points of the disease, specifically, at the time of diagnosis, during follow-up, and 1 and 2 years after discontinuation of antiepileptic drugs. METHODS: Our study included 50 patients between 5 and 14 years of age, who were diagnosed with childhood absence epilepsy or idiopathic focal epilepsy with Rolandic paroxysms. Parents of the participants independently completed the Parenting Stress Index-Short Form at the time of initial diagnosis, and when the children started antiepileptic drugs (Time 0), and at 1 year (Time 1) and 2 years (Time 2) after discontinuation of therapy...
May 2019: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/30970205/recent-advances-in-the-neurosurgical-treatment-of-pediatric-epilepsy-jnspg-75th-anniversary-invited-review-article
#40
REVIEW
Jarod Roland, Matthew Smyth
The field of epilepsy surgery has seen tremendous growth in recent years. Innovative new devices have driven much of this growth, but some has been driven by revisions of existing products. Devices have also helped to rejuvenate existing procedures, as in the case of robotic assistance for electrode placement for stereo-electroencephalography, and these devices have brought significant attention along with their introduction. Other devices, such as responsive neurostimulators or laser interstitial thermal therapy systems, have introduced novel treatment modalities and broadened the surgical indications...
April 5, 2019: Journal of Neurosurgery. Pediatrics
keyword
keyword
171890
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.